Virtual Reality for Alcoholism
(HOME Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new virtual reality (VR) program designed to help individuals with alcohol use disorder (AUD) reduce alcohol consumption and maintain sobriety. The researchers aim to determine if the VR experience can encourage participants to focus on their future, make better long-term decisions, and choose delayed rewards over immediate ones. Participants will be divided into two groups: one will try the VR program, while the other will receive standard care for comparison. This trial suits those who have been sober for at least 14 days but no more than a year, are committed to recovery, and can understand English. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could shape future treatments for AUD.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does allow the use of psychotropic drugs for substance use disorder (SUD) comorbidity. It's best to discuss your specific medications with the trial coordinators.
What prior data suggests that this virtual reality intervention is safe for early recovering alcohol use disorder persons?
Research has shown that virtual reality (VR) is generally safe and well-received for treating alcohol use problems. For example, one study found that VR helped reduce alcohol cravings without major safety issues. Another study showed that people using VR therapy drank less alcohol compared to those receiving regular therapy, suggesting VR's effectiveness and safety.
While VR appears promising, some studies note that individuals may respond differently to it, meaning it might work better for some than others. However, no major side effects or safety problems have been reported. VR also provides a controlled and safe way to practice managing cravings and avoiding relapse.
In summary, evidence supports VR as a safe and potentially effective treatment option for reducing alcohol use.12345Why are researchers excited about this trial?
Researchers are excited about using virtual reality (VR) for treating alcoholism because it offers a unique, immersive approach that differs from traditional methods like medication and therapy. Unlike standard treatments, which typically involve counseling or medication to reduce cravings, VR creates a controlled environment where individuals can safely practice coping strategies and decision-making skills. This hands-on experience can help people better prepare for real-world situations that might trigger their alcohol use. Additionally, VR's engaging nature may increase patient motivation and adherence to treatment, potentially leading to better outcomes.
What evidence suggests that this virtual reality intervention is effective for reducing alcohol use?
Research has shown that virtual reality (VR) can help treat alcohol use disorder (AUD). Studies have found that VR can reduce alcohol cravings and serve as a valuable therapy component. In this trial, participants in the Virtual Reality arm will receive VR interventions, which may help manage cravings, especially for those who drink heavily in social settings. Additionally, combining VR with cognitive-behavioral therapy (CBT) has proven effective for treating AUD. These findings suggest that VR might help people with AUD drink less and maintain sobriety.34678
Who Is on the Research Team?
Brandon G Oberlin, PhD
Principal Investigator
Indiana University
Are You a Good Fit for This Trial?
This trial is for individuals in early recovery from alcohol use disorder (AUD). Participants should be interested in using virtual reality as a tool to help with their recovery. Specific eligibility criteria are not provided, but typically these would include factors like age range, severity of AUD, and willingness to adhere to the study protocol.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a Virtual Reality intervention to test for efficacy in reducing alcohol use and increasing abstinence
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 30-day and 6-month intervals
What Are the Treatments Tested in This Trial?
Interventions
- Virtual Reality
Virtual Reality is already approved in United States for the following indications:
- Functional Dyspepsia
- Irritable Bowel Syndrome (IBS)
- Gastroparesis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator